An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. Williams, Jones, Siân, Zhang, Xiaosong, Lin, Jimmy Cheng-Ho, Leary, Rebecca J., Angenendt, Philipp, Mankoo, Parminder, Carter, Hannah, Siu, I-Mei, Gallia, Gary L., Olivi, Alessandro, McLendon, Roger, Rasheed, B. Ahmed, Keir, Stephen, Nikolskaya, Tatiana, Nikolsky, Yuri, Busam, Dana A., Tekleab, Hanna, Diaz, Luis A., Hartigan, James, Smith, Doug R., Strausberg, Robert L., Marie, Suely Kazue Nagahashi, Shinjo, Sueli Mieko Oba, Yan, Hai, Riggins, Gregory J., Bigner, Darell D., Karchin, Rachel, Papadopoulos, Nick, Parmigiani, Giovanni, Vogelstein, Bert, Velculescu, Victor E., Kinzler, Kenneth W.·2008·Science
DOI 10.1126/science.1164382

Cited by (1,034)

Items 301–400 of 1,034

  1. Driver and Passenger Mutations in Cancer
    Julia R. Pon, Marco A. Marra · 2014 · Annual Review of Pathology Mechanisms of Disease
  2. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas
    Olar, Adriana, Wani, Khalida M., Alfaro-Munoz, Kristin D., Heathcock, Lindsey E., van Thuijl, Hinke F., Gilbert, Mark R., Armstrong, Terri S., Sulman, Erik P., Cahill, Daniel P., Vera-Bolanos, Elizabeth et al. · 2015 · Acta Neuropathologica
  3. The molecular determinants of de novo nucleotide biosynthesis in cancer cells
    Tong, Xuemei, Zhao, Fangping, Thompson, Craig B · 2009 · Current Opinion in Genetics & Development
  4. Whole Genome Sequencing
    Pauline C. Ng, Ewen F. Kirkness · 2010 · Methods in molecular biology
  5. Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets
    Junfeng Bi, Sudhir Chowdhry, Sihan Wu, Wenjing Zhang, Kenta Masui, Paul S. Mischel · 2019 · Nature reviews. Cancer
  6. Central Nervous System Tumors
    Jan C. Buckner, Paul D. Brown, Brian Patrick O’Neill, Fredric Bruce Meyer, Cynthia Wetmore, Joon H. Uhm · 2007 · Mayo Clinic Proceedings
  7. Prognostic and Predictive Biomarkers in Gliomas
    Paulina Śledzińska, Marek G. Bebyn, Jacek Furtak, Janusz Kowalewski, Marzena Anna Lewandowska · 2021 · International Journal of Molecular Sciences
  8. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
    Andrey Korshunov, Marina Vladimirovna Ryzhova, Volker Hovestadt, Sebastian Bender, Dominik Sturm, David Capper, Jochen Meyer, Daniel Schrimpf, Marcel Kool, Paul A. Northcott et al. · 2015 · Acta Neuropathologica
  9. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
    Syreeta DeCordova, Abhishek Shastri, Anthony George Tsolaki, Hadida Yasmin, Lukas Klein, Shiv K. Singh, Uday Kishore · 2020 · Frontiers in Immunology
  10. Synergy effects of herb extracts: Pharmacokinetics and pharmacodynamic basis
    Yong Yang, Zaiqi Zhang, Shuping Li, Xiaoli Ye, Xuegang Li, Kai He · 2013 · Fitoterapia
  11. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
    Hilde Brems, Eline Beert, Thomy J.L. de Ravel, Eric Legius · 2009 · The Lancet Oncology
  12. Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
    Igor Vivanco, H. Ian Robins, Daniel Rohle, Carl Campos, Christian Grommes, Phioanh Leia Nghiemphu, Sara Kubek, Barbara Oldrini, Milan G. Chheda, Nicolas A. Yannuzzi et al. · 2012 · Cancer Discovery
  13. Unveiling the role of network and systems biology in drug discovery
    Albert Pujol, Roberto Mosca, Judith Farrés, Patrick Aloy · 2010 · Trends in Pharmacological Sciences
  14. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
    Huimin Hu, Quanhua Mu, Zhaoshi Bao, Yiyun Chen, Yanwei Liu, Jing Chen, Kuanyu Wang, Zheng Wang, Yoonhee Nam, Biaobin Jiang et al. · 2018 · Cell
  15. CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
    Jianfeng Han, Jianhong Chu, Wing Keung Chan, Jianying Zhang, Youwei Wang, Justus B. Cohen, Aaron R. Victor, Walter Hans Meisen, Sung-Hak Kim, Paola Grandi et al. · 2015 · Scientific Reports
  16. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
    Walter W. Chen, Leonora Balaj, Linda M. Liau, Michael L. Samuels, Steve K. Kotsopoulos, Casey A. Maguire, Lori LoGuidice, Horacio Soto, Matthew C. Garrett, Lin Dan Zhu et al. · 2013 · Molecular Therapy — Nucleic Acids
  17. Long non-coding RNA expression profiles predict clinical phenotypes in glioma
    Xiaoqin Zhang, Stella Sun, Jenny Kan Suen Pu, Anderson Chun On Tsang, Derek Lee, Venus On Ying Man, Wai‐Man Lui, Thian‐Sze Wong, Gkk Leung · 2012 · Neurobiology of Disease
  18. A pathway-based classification of human breast cancer
    Michael L. Gatza, Joseph E. Lucas, William Thomas Barry, Jong Wook Kim, Quanli Wang, Matthew D. Crawford, Michael Datto, Michael J. Kelley, Bernard Mathey-Prévôt, Anil Potti et al. · 2010 · Proceedings of the National Academy of Sciences
  19. Genomics-Driven Oncology: Framework for an Emerging Paradigm
    Levi A. Garraway · 2013 · Journal of Clinical Oncology
  20. Making sense of cancer genomic data
    Lynda Chin, William C. Hahn, Gad A. Getz, Matthew M. Meyerson · 2011 · Genes & Development
  21. Developing therapeutic microRNAs for cancer
    Andreas G. Bader, D Brown, Jay Stoudemire, Paul Lammers · 2011 · Gene Therapy
  22. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
    Mullarky, Edouard, Lucki, Natasha C., Beheshti Zavareh, Reza, Anglin, Justin L., Gomes, Ana P., Nicolay, Brandon N., Wong, Jenny C. Y., Christen, Stefan, Takahashi, Hidenori, Singh, Pradeep K. et al. · 2016 · Proceedings of the National Academy of Sciences
  23. IDH1 and IDH2 Mutations in Gliomas
    Joon H. Uhm · 2009 · Yearbook of Neurology and Neurosurgery
  24. Biological Role and Therapeutic Potential of IDH Mutations in Cancer
    Matthew S. Waitkus, Bill H. Diplas, Hai Yan · 2018 · Cancer Cell
  25. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
    Martin J. van den Bent, C. Mircea S. Tesileanu, Wolfgang Wick, Marc Sanson, Alba Ariela Brandes, Paul M. Clément, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean Français Baurain et al. · 2021 · The Lancet Oncology
  26. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells
    Jin‐Qiang Chen, José Russo · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  27. Automated Network Analysis Identifies Core Pathways in Glioblastoma
    Ethan G Cerami, Emek Demir, Nikolaus D. Schultz, Barry S. Taylor, Chris Sander · 2010 · PLoS ONE
  28. Glioblastoma multiforme: State of the art and future therapeutics
    DavidH. Harter, TaylorA Wilson, Matthias A. Karajannis · 2014 · Surgical Neurology International
  29. Functional impact bias reveals cancer drivers
    Abel González-Pérez, Núria López-Bigas · 2012 · Nucleic Acids Research
  30. An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
    Genaro R. Villa, Jonathan J. Hulce, Ciro Zanca, Junfeng Bi, Shiro Ikegami, Gabrielle L. Cahill, Yuchao Gu, Kenneth M. Lum, Kenta Masui, Huijun Yang et al. · 2016 · Cancer Cell
  31. Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer
    Marco Sciacovelli, Christian Frezza · 2017 · FEBS Journal
  32. Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma
    Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Elizabeth Anne Maher, Macarena I. de la Fuente, Matthias Holdhoff, Gregory Michael Cote, Howard A. Burris, Filip Jankú, Robert J. Young et al. · 2020 · Journal of Clinical Oncology
  33. Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
    Karine Michaud, David A. Solomon, Eric Karl Oermann, Jung-Sik Kim, Wei-Zhu Zhong, Michael D. Prados, Tomoko Ozawa, Charles David James, Todd A. Waldman · 2010 · Cancer Research
  34. Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
    Wojciech Szopa, Thomas A. Burley, Gabriela Krämer-Marek, Wojciech Kaspera · 2017 · BioMed Research International
  35. The 2016 World Health Organization classification of tumours of the central nervous system
    Chiara Villa, Catherine Miquel, Dominic Mosses, Michèle Bernier, Anna Luisa Di Stefano · 2018 · La Presse Médicale
  36. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
    Pope, Whitney B., Prins, Robert M., Albert Thomas, M., Nagarajan, Rajakumar, Yen, Katharine E., Bittinger, Mark A., Salamon, Noriko, Chou, Arthur P., Yong, William H., Soto, Horacio et al. · 2012 · Journal of Neuro-Oncology
  37. Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma
    Barbara S. Paugh, Alberto Broniscer, Chunxu Qu, Claudia P. Miller, Junyuan Zhang, Ruth Tatevossian, James M. Olson, Jeffrey Russell Geyer, Susan N Chi, Nasjla Saba da Silva et al. · 2011 · Journal of Clinical Oncology
  38. Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
    James G. Taylor, Adam Cheuk, Patricia S. Tsang, Joon‐Yong Chung, Young Song, Krupa D. Desai, Yanlin Yu, Qingrong Chen, Kushal J. Shah, Victoria Youngblood et al. · 2009 · Journal of Clinical Investigation
  39. IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
    Ayalew Tefferi, Terra L. Lasho, Omar Ibrahim Abdel-Wahab, Paola Guglielmelli, Jay L. Patel, Domenica Caramazza, Lisa Pieri, Christy M. Finke, Outi Kilpivaara, Martha Wadleigh et al. · 2010 · Leukemia
  40. Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
    Ellen Margrethe Haugsten, Antoni Więdłocha, Sjur Olsnes, Jørgen Wesche · 2010 · Molecular Cancer Research
  41. Current trends in the surgical management and treatment of adult glioblastoma.
    Richard M Young, Aria M. Jamshidi, Gregory Davis, Jonathan H. Sherman · 2015 · Europe PMC (PubMed Central)
  42. BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
    Dora C. Dias-Santagata, Quynh Lam, Kathy Vernovsky, Natalie Vena, Jochen K. Lennerz, Darrell R. Borger, Tracy T. Batchelor, Keith Lloyd Ligon, Anthony John Iafrate, Azra Hadi Ligon et al. · 2011 · PLoS ONE
  43. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
    Horbinski, Craig, Berger, Tamar, Packer, Roger J., Wen, Patrick Y. · 2022 · Nature Reviews Neurology
  44. Spatiotemporal Evolution of the Primary Glioblastoma Genome
    Jinkuk Kim, In‐Hee Lee, Hee Jin Cho, Chul‐Kee Park, Yang-Soon Jung, Yanghee Kim, So Hee Nam, Byung Sup Kim, Mark D. Johnson, Doo‐Sik Kong et al. · 2015 · Cancer Cell
  45. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers
    Mi Ran Kang, Min Sung Kim, Ji Eun Oh, Yoo Ri Kim, Sang Yong Song, Seong Il Seo, Ji Youl Lee, Nam Jin Yoo, Sug Hyung Lee · 2009 · International Journal of Cancer
  46. New aspects of the Warburg effect in cancer cell biology
    Steven J. Bensinger, Heather R. Christofk · 2012 · Seminars in Cell and Developmental Biology
  47. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
    Shota Tanaka, David N. Louis, William T. Curry, Tracy T. Batchelor, Jörg Dietrich · 2012 · Nature Reviews Clinical Oncology
  48. Impact of deleterious passenger mutations on cancer progression
    Christopher D. McFarland, Kirill S. Korolev, Gregory V. Kryukov, Shamil R. Sunyaev, Leonid A. Mirny · 2013 · Proceedings of the National Academy of Sciences
  49. Role of mitochondrial dysfunction in cancer progression
    Chia‐Chi Hsu, Ling‐Ming Tseng, Hsin‐Chen Lee · 2016 · Experimental Biology and Medicine
  50. Dysregulated metabolism contributes to oncogenesis
    Matthew D. Hirschey, Ralph J. DeBerardinis, Anna Mae Diehl, Janice E. Drew, Christian Frezza, Michelle F. Green, Lee W. Jones, Young Hee Ko, Anne Le, Michael Anthony Lea et al. · 2015 · Seminars in Cancer Biology
  51. The NF1 somatic mutational landscape in sporadic human cancers
    Charlotte Philpott, Hannah Tovell, Ian M. Frayling, D.N. Cooper, Meena Upadhyaya · 2017 · Human Genomics
  52. The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
    Fonnet E. Bleeker, Nadia A. Atai, Simona Lamba, Ard Jonker, Denise Rijkeboer, Klazien S. Bosch, Wikky Tigchelaar, Dirk Troost, William Peter Vandertop, Alberto Bardelli et al. · 2010 · Acta Neuropathologica
  53. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
    Tathiane Maistro Malta, Camila Ferreira de Souza, Thaís S. Sabedot, Tiago C. Silva, Maritza S. Mosella, Steven N. Kalkanis, James Snyder, Ana Valeria B. Castro, Houtan Noushmehr · 2017 · Neuro-Oncology
  54. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
    Camilla Krakstad, Martha Chekenya · 2010 · Molecular Cancer
  55. Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
    Vadas, Oscar, Burke, John E., Zhang, Xuxiao, Berndt, Alex, Williams, Roger L. · 2011 · Science Signaling
  56. A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane
    Diana L. Mandelker, Sandra B. Gabelli, Oleg Schmidt‐Kittler, Jiuxiang Zhu, Ian Cheong, Chuan‐Hsiang Huang, Kenneth W. Kinzler, Bert Vogelstein, L. Mario Amzel · 2009 · Proceedings of the National Academy of Sciences
  57. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer
    Ali Bashashati, Gholamreza Haffari, Jiarui Ding, Gavin Ha, Kenneth Lui, Jamie Rosner, David D. Huntsman, Carlos Caldas, Samuel A. J. R. Aparicio, Sohrab P. Shah · 2012 · Genome biology
  58. Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma
    Jose Carrillo, Albert Lai, Phioanh Leia Nghiemphu, H.J. Kim, HEIDI S. PHILLIPS, Samir Kharbanda, Parham Moftakhar, S. Lalaezari, W. H. Yong, Benjamin M. Ellingson et al. · 2012 · American Journal of Neuroradiology
  59. Cancer-associated IDH mutations: biomarker and therapeutic opportunities
    Yen, K E, Bittinger, M A, Su, S M, Fantin, V R · 2010 · Oncogene
  60. D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
    Sasaki, Masato, Knobbe, Christiane B., Itsumi, Momoe, Elia, Andrew J., Harris, Isaac S., Chio, Iok In Christine, Cairns, Rob A., McCracken, Susan, Wakeham, Andrew, Haight, Jillian et al. · 2012 · Genes & Development
  61. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K
    Carrie L. Lucas, Yu Zhang, Anthony C. Venida, Ying Wang, Jason D. Hughes, Joshua J. McElwee, Morgan Butrick, Helen F Matthews, Susan M Price, Matthew Biancalana et al. · 2014 · The Journal of Experimental Medicine
  62. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
    Chris Jones, Suzanne J. Baker · 2014 · Nature reviews. Cancer
  63. Mitochondria and Reactive Oxygen Species
    Francesco Addabbo, Monica Montagnani, Michael S. Goligorsky · 2009 · Hypertension
  64. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
    Sameer Agnihotri, Gelareh Mohammed Zadeh · 2015 · Neuro-Oncology
  65. Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma
    Qi‐Wen Fan, Christine Cheng, Chris Hackett, Morri E. Feldman, Benjamin T. Houseman, Theodore P. Nicolaides, Daphne Adele Haas-Kogan, Charles David James, Scott A. Oakes, Jayanta Debnath et al. · 2010 · Science Signaling
  66. A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
    Surojit Sur, Raymond A. Pagliarini, Fred Bunz, Carlo Rago, Luis Alberto Diaz, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos · 2009 · Proceedings of the National Academy of Sciences
  67. Progress in understanding 2‐hydroxyglutaric acidurias
    Kranendijk, Martijn, Struys, Eduard A., Salomons, Gajja S., Van der Knaap, Marjo S., Jakobs, Cornelis · 2012 · Journal of Inherited Metabolic Disease
  68. Oncogenic Mutations of PIK3CA in Human Cancers
    Samuels, Yardena, Waldman, Todd · 2010 · Current Topics in Microbiology and Immunology
  69. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
    Adam M. Fontebasso, Jeremy Schwartzentruber, Dong-Anh Khuong-Quang, Xiao-Yang Liu, Dominik Sturm, Andrey Korshunov, David Jones, Hendrik Witt, Marcel Kool, Steffen Albrecht et al. · 2013 · Acta Neuropathologica
  70. Cooperativity within and among Pten, p53, and Rb Pathways Induces High-Grade Astrocytoma in Adult Brain
    Lionel M.L. Chow, Raelene Endersby, Xiaoyan Zhu, Sherri L. Rankin, Chunxu Qu, Junyuan Zhang, Alberto Broniscer, David W. Ellison, Suzanne J. Baker · 2011 · Cancer Cell
  71. IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
    Songtao Qi, Lei Yu, Si Gui, Ding YanQing, Han HuiXia, Zhang Xue-lin, Wu Lanxiao, Yao Fei · 2011 · Cancer Science
  72. BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
    Matthew Mistry, Nataliya Zhukova, Daniele Merico, Patricia Rakopoulos, Rahul Krishnatry, Mary Shago, James Stavropoulos, Noa Alon, Jason D. Pole, Peter N. Ray et al. · 2015 · Journal of Clinical Oncology
  73. Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
    Bijay Shankar Jaiswal, Vasantharajan Janakiraman, Noelyn M. Kljavin, Subhra Chaudhuri, Howard Marvin Stern, Weiru Wang, Zhengyan Kan, Hashem A. Dbouk, Brock A. Peters, Paul Waring et al. · 2009 · Cancer Cell
  74. EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
    Francis, Joshua M., Zhang, Cheng-Zhong, Maire, Cecile L., Jung, Joonil, Manzo, Veronica E., Adalsteinsson, Viktor A., Homer, Heather, Haidar, Sam, Blumenstiel, Brendan, Pedamallu, Chandra Sekhar et al. · 2014 · Cancer Discovery
  75. A network view of disease and compound screening
    Eric E. Schadt, Stephen Henry Friend, David A. Shaywitz · 2009 · Nature Reviews Drug Discovery
  76. Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
    Philippe Métellus, Béma Coulibaly, Carole Colin, A. Maues de Paula, Alexandre Vasiljevic, David Taïeb, Anne Barlier, Blandine Boisselier, Karima Mokhtari, Xiao Wei Wang et al. · 2010 · Acta Neuropathologica
  77. Glioma: experimental models and reality
    Krissie Lenting, Roel G.W. Verhaak, Mark ter Laan, Pieter Wesseling, William P. J. Leenders · 2017 · Acta Neuropathologica
  78. Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative Neoplasms
    Anthony Richard Green, Philip A. Beer · 2010 · New England Journal of Medicine
  79. Brain exposure of two selective dual CDK4 and CDK6 inhibitors and the antitumor activity of CDK4 and CDK6 inhibition in combination with temozolomide in an intracranial glioblastoma xenograft
    Raub, Thomas J., Wishart, Graham N., Kulanthaivel, Palaniappan, Staton, Brian A., Ajamie, Rose T., Sawada, Geri A., Gelbert, Lawrence M., Shannon, Harlan E., Sanchez-Martinez, Concepcion, De Dios, Alfonso · 2015 · Drug Metabolism and Disposition
  80. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches
    Manfred Westphal, Katrin Lamszus · 2011 · Nature reviews. Neuroscience
  81. Molecular diagnostics of gliomas: state of the art
    Markus J. Riemenschneider, Judith W. M. Jeuken, Pieter Wesseling, Guido Reifenberger · 2010 · Acta Neuropathologica
  82. Isocitrate dehydrogenase mutations in gliomas
    Matthew S. Waitkus, Bill H. Diplas, Hai Yan · 2015 · Neuro-Oncology
  83. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
    David Reuß, Annekathrin Kratz, Felix Sahm, David Capper, Daniel Schrimpf, Christian Koelsche, Volker Hovestadt, Melanie Bewerunge‐Hudler, David Jones, Jens Schittenhelm et al. · 2015 · Acta Neuropathologica
  84. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism
    Grassian, Alexandra R., Parker, Seth J., Davidson, Shawn M., Divakaruni, Ajit S., Green, Courtney R., Zhang, Xiamei, Slocum, Kelly L., Pu, Minying, Lin, Fallon, Vickers, Chad et al. · 2014 · Cancer Research
  85. High-resolution characterization of a hepatocellular carcinoma genome
    Yasushi Totoki, Kenji Tatsuno, Shogo Yamamoto, Yasuhito Arai, Fumie Hosoda, Shumpei Ishikawa, Shuichi Tsutsumi, Kohtaro Sonoda, Hirohiko Totsuka, Takuya Shirakihara et al. · 2011 · Nature Genetics
  86. In vivo models of primary brain tumors: pitfalls and perspectives
    Peter Csaba Huszthy, Inderjit Daphu, Simone P. Niclou, Daniel Stieber, Janice M. Nigro, Per Øystein Sakariassen, Hrvoje Miletić, Frits Thorsen, Rolf Bjerkvig · 2012 · Neuro-Oncology
  87. Signaling through cyclin D-dependent kinases
    Yoojin Choi, Lars Anders · 2013 · Oncogene
  88. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
    Heidi E. Greulich, Bethany Kaplan, Philipp Mertins, Tzu-Hsiu Chen, Kumiko Tanaka, Cai‐Hong Yun, Xiaohong Zhang, Se‐Hoon Lee, Jeonghee Cho, Lauren Ambrogio et al. · 2012 · Proceedings of the National Academy of Sciences
  89. Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease
    Eliseo Papa, Michael Docktor, Christopher S. Smillie, Sarah Weber, Sarah Pacocha Preheim, Dirk Gevers, Georgia Giannoukos, Dawn Ciulla, Diana Tabbaa, Jay Ingram et al. · 2012 · PLoS ONE
  90. Cancer heterogeneity—a multifaceted view
    Felipe de Sousa e Melo, Louis Vermeulen, Evelyn Fessler, Jan Paul Medema · 2013 · EMBO Reports
  91. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
    Siân Jones, Meng Li, Donald Williams Parsons, Xiaosong Zhang, Jelle Wesseling, Petra Kristel, Marjanka K. Schmidt, Sanford D. Markowitz, Hai Yan, Darell D. Bigner et al. · 2011 · Human Mutation
  92. Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
    Kasthuri S. Kannan, Akiko Inagaki, Joachim Silber, Daniel J. Gorovets, Jianan Zhang, Edward R. Kastenhuber, Adriana Heguy, John H.J. Petrini, Timothy An-thy Chan, Jason T. Huse · 2012 · Oncotarget
  93. The disturbed blood–brain barrier in human glioblastoma
    Hartwig Wolburg, Susan Noell, Petra Fallier‐Becker, Andreas F. Mack, Karen Wolburg‐Buchholz · 2012 · Molecular Aspects of Medicine
  94. All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
    Marianne Labussière, Ahmed Idbaïh, X.-W. Wang, Yannick Marie, Blandine Boisselier, C. Falet, Sophie Paris, Julien Laffaire, C. Carpentier, Emmanuelle Crinière et al. · 2010 · Neurology
  95. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
    Andrey Korshunov, Jochen Meyer, David Capper, Arne Christians, Marc Remke, Hendrik Witt, Stefan Michael Pfister, Andreas von Deimling, Christian Johannes Hartmann · 2009 · Acta Neuropathologica
  96. The Influence of Metabolism on Drug Response in Cancer
    Zaal, Esther A., Berkers, Celia R. · 2018 · Frontiers in Oncology
  97. Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
    Sameer Agnihotri, Kelly E. Burrell, Amparo Wolf, Sharzhad Jalali, Cynthia E Hawkins, James T. Rutka, Gelareh Mohammed Zadeh · 2012 · Archivum Immunologiae et Therapiae Experimentalis
  98. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers
    Michael Jansen, Stephen S. F. Yip, David N. Louis · 2010 · The Lancet Neurology
  99. Principles of using Cold Atmospheric Plasma Stimulated Media for Cancer Treatment
    Dayun Yan, Annie Talbot, Niki Nourmohammadi, Xiaoqian Cheng, Jerome Canady, Jonathan H. Sherman, Michael Keidar · 2015 · Scientific Reports
  100. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
    Yuanyan Wei, Yi‐Zhou Jiang, Fei Zou, Yingchao Liu, Shanshan Wang, Nuo Xu, Wenlong Xu, Chunhong Cui, Yang Xing, Ying Liu et al. · 2013 · Proceedings of the National Academy of Sciences